Symbol
|
RMAJQV | Z09YJZ | Z0A1RZ | Z0ALWZ | Z0ASJZ | Z0ATQZ | SKS6LK |
---|---|---|---|---|---|---|---|
Nom | Multi Vonti | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | Autocallable Reverse Convertible Defensive worst | LUKB Softcallable Multi Reverse Convertible |
Sous-jacent
|
Galderma Group AG / Galenica AG / Sandoz Group AG | Galderma Group AG / Sandoz Group AG / VAT Group | Galderma Group AG / Lonza Group N / Sandoz Group AG | Alcon / Galderma Group AG / Siegfried Hldg. AG | Galderma Group AG / Sika AG / Swiss Life Hldg. N | Galderma Group AG / Sandoz Group AG / SIG Combibloc / VAT Group | Galderma Group AG / Novartis AG / Sika AG |
Emetteur
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Échéance
|
30.06.2025 | 02.03.2026 | 16.09.2025 | 27.07.2026 | 27.08.2026 | 07.09.2026 | 07.04.2027 |
Ratio | - | - | - | - | - | - | - |
Prix d'exercise
|
26,16 | 29,2061 | 67,5325 | 91,805 | 602,77 | 251,269 | 75,528 |
rendement max. p.a. | 0,80% | 30,84% | 9,08% | 13,75% | 14,36% | 16,90% | 8,48% |
Demande | 99,80 | - | - | - | - | - | - |
Offre | 101,20 | - | - | - | - | - | - |